TRXB — TRex Bio, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2139097 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $233.82B | $432.49 | — |
| GILD | GILEAD SCIENCES, INC. | $193.67B | $156.19 | — |
| MRNA | Moderna, Inc. | $87.04B | $218.01 | — |
| ARGX | ARGENX SE | $50.94B | $819.14 | — |
| RVMD | Revolution Medicines, Inc. | $38.14B | $177.96 | — |
News headlines (Yahoo Finance, 1h cache)
TRexBio Announces Closing of Initial Public Offering
2026-10-13 20:47 · Yahoo
TRexBio Announces Pricing of Initial Public Offering
2026-10-09 01:29 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-15 16:33:52 | 2026-10-13 | Alexandria Venture Investments, LLC | 10% | P - Purchase | 14 | 178571 | 2499994 |
| 2026-10-13 16:30:01 | 2026-10-08 | Svlsf Vi, LLC | 10% | P - Purchase | 14 | 92857 | 1299998 |